drugset / Trial / NCT03559985

Paracetamol and Neuropathic Pain

NCT03559985

Phase 2 Terminated 43 enrolled University Hospital, Clermont-Ferrand
RandomizedCrossoverQuadruple-blindTreatment

Summary

The aim of this study is to evaluate the analgesic effect of paracetamol in patients suffering from pain with a peripheral neuropathic component in the presence of their usual treatment.

Timeline

Start
2018-08-20
Primary completion
2020-10-08
Completion
2022-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg

Indications